Fenoksipropazin
Fenoksipropazin (prodajno ime Drazin) je ireverzibilni i neselektivni inhibitor monoaminoksidaze (MAOI) iz hidrazinske hemijske klase. On je uveden u upotrebu kao antidepresiv 1961, ali je naknadno povućen sa tržišta 1966. zbog moguće pojave hepatotoksičnosti.[1][2][3][4][5]
IUPAC ime | |
---|---|
(1-metil-2-fenoksi-etil)hidrazin | |
Klinički podaci | |
Način primene | Oralno |
Pravni status | |
Pravni status |
|
Identifikatori | |
CAS broj | 3818-37-9 |
ATC kod | none |
PubChem | CID 71467 |
ChemSpider | 64548 |
UNII | 8E92V52324 |
ChEMBL | CHEMBL1909286 |
Hemijski podaci | |
Formula | C9H14N2O |
Molarna masa | 166,22 g/mol |
Vidi još
urediReference
uredi- ^ LEAHY MR, ROSE JT, PLOWMAN R (1963). „A preliminary study of phenoxypropazine in the treatment of depression”. The American Journal of Psychiatry. 119: 986—7. PMID 13928824.
- ^ IMLAH NW (1963). „Preliminary report on phenoxypropazine”. The American Journal of Psychiatry. 119: 1091—2. PMID 13956423.
- ^ ROSE JT, LEAHY MR, PLOWMAN R (1963). „A comparison of phenoxypropazine and amitriptyline in depression”. The American Journal of Psychiatry. 120: 393—5. PMID 14069469.
- ^ ROSE JT (1964). „Phenoxypropazine and chlordiazepoxide in depression”. The American Journal of Psychiatry. 120: 899—900. PMID 14129290.
- ^ MCWHINNEY IR, MORRELL DC (1965). „Treatment of mild endogenous depression with a monoamine oxidase inhibitor: a controlled trial in general practice”. The Journal of the College of General Practitioners. 9: 95—9. PMC 1878242 . PMID 14254271.